Intracutaneous Sterile Water Injections for Acute Low Back Pain in the Emergency Department
Stopped early · Not applicable
Conditions studied: Low Back Pain
In brief
The purpose of this study is to evaluate the efficacy of intracutaneous sterile water injections (ISWI) for treatment of acute low back pain in patients presenting to the emergency department. The primary aim is to determine if ISWI provides pain relief for acute low back pain in the ED. The secondary aim is to evaluate whether ISWI provides improved patient satisfaction in the ED setting. The hypothesis is that ISWI will improve pain amongst patients presenting with acute low back pain to the ED.
Key facts
- Study ID
- NCT04240483
- Run by
- Lindsey schmelzer
- People needed
- 6
- Starts
- 2020-07-27
- Expected to finish
- 2021-02-08
- Last updated by the study team
- 2022-01-28
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Active Duty and DoD Beneficiaries aged 18 to 64 years.
- Presenting to the ED with a chief complaint of acute low back pain of less than 2 weeks in duration.
- Pain severity on presentation of greater than or equal to 5/10 on Visual Analogue Scale.
You may not qualify if…
- Traumatic low back pain
- New weakness or neurologic deficit
- New loss bowel/bladder control
- Back pain above T12
- Active cancer
- Currently taking anticoagulant medications
- Signs of infection or trauma over the injection site
- Non-English speaking
- Pregnancy
Where it is running
- Mike O'Callaghan Military Medical Center — Nellis Air Force Base, Nevada, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.